Evidence Hub

Combined sodium aescinate and calf blood extract gel for corneal foreign body injury

Wang X, Sun Y, Zhao Q

Pakistan journal of pharmaceutical sciences, 2025

270 participants

Abstract

The aim of this study was to assess the efficacy of combining sodium aescinate tablets with deproteinized calf blood extract eye gel (DCB-EG) in treating corneal foreign body injuries. This retrospective study included 270 patients divided into three groups: Combination (sodium aescinate + DCB-EG, n=90), Gel (DCB-EG, n=90) and Control (routine anti-infection, n=90). Primary outcome was clinical efficacy rate; secondary outcomes included pain scores (VAS), corneal healing metrics, inflammatory markers (IFN-γ, TNF-α, IL-17), tear film stability (BUT), corneal epithelial status (CESS), tear secretion (SIt) and ocular surface disease index (OSDI). Data were analyzed using ANOVA or Chi-square test. The research results showed that the Combination group achieved the highest efficacy (98.89%), significantly better than the Gel (91.11%) and Control (86.67%) groups (P0.05). The combination therapy provided a safe and optimized treatment method for corneal foreign body injuries.

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 270 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free